The prolyl oligopeptidase family

被引:272
作者
Polgár, L [1 ]
机构
[1] Hungarian Acad Sci, Inst Enzymol, H-1518 Budapest, Hungary
关键词
serine peptidases; oligopeptidases; prolyl oligopeptidase; dipeptidyl peptidase; oligopeptidase B; acyl-aminoacyl peptidase; beta-propeller structure; catalytic mechanism;
D O I
10.1007/s00018-002-8427-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A group of serine peptidases, the prolyl oligopeptidase family, cannot hydrolyze peptides containing more than about 30 residues. This group is unrelated to the classical trypsin and subtilisin families, and includes dipeptidyl peptidase IV, acylaminoacyl peptidase and oligopeptidase B, in addition to the prototype prolyl oligopeptidase. The recent crystal structure determination of prolyl oligopeptidase (80 kDa) has shown that the enzyme contains a peptidase domain with an alpha/beta hydrolase fold, and its catalytic triad is covered by the central tunnel of an unusual seven-bladed beta-propeller. This domain operates as a gating filter, excluding large, structured peptides from the active site. The binding mode of substrates and the catalytic mechanism differ from that of the classical serine peptidases in several features. The members of the family are important targets of drug design. Prolyl oligopeptidase is involved in amnesia, depression and blood pressure control, dipeptidyl peptidase IV in type 2 diabetes and oligopeptidase B in trypanosomiasis.
引用
收藏
页码:349 / 362
页数:14
相关论文
共 156 条
[1]   GENOMIC ORGANIZATION, EXACT LOCALIZATION, AND TISSUE EXPRESSION OF THE HUMAN CD26 (DIPEPTIDYL PEPTIDASE-IV) GENE [J].
ABBOTT, CA ;
BAKER, E ;
SUTHERLAND, GR ;
MCCAUGHAN, GW .
IMMUNOGENETICS, 1994, 40 (05) :331-338
[2]  
Ansorge S, 1997, ADV EXP MED BIOL, V421, P127
[3]   SUBSTRATE-SPECIFICITY AND INHIBITOR SENSITIVITY OF A TRYPANOSOMATID ALKALINE PEPTIDASE [J].
ASHALL, F ;
HARRIS, D ;
ROBERTS, H ;
HEALY, N ;
SHAW, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1035 (03) :293-299
[4]   INVITRO AND INVIVO INHIBITION OF PROLYL ENDOPEPTIDASE [J].
ATACK, JR ;
SUMANCHAUHAN, N ;
DAWSON, G ;
KULAGOWSKI, JJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (02) :157-163
[5]   THE INVOLVEMENT OF DIPEPTIDYL PEPTIDASE-IV IN BRUSH-BORDER DEGRADATION OF GRF(1-29)NH2 BY INTESTINAL MUCOSAL CELLS [J].
BAI, JPF ;
CHANG, LL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (08) :698-701
[6]   Cytochrome cd(1) structure: Unusual haem environments in a nitrite reductase and analysis of factors contributing to beta-propeller folds [J].
Baker, SC ;
Saunders, NFW ;
Willis, AC ;
Ferguson, SJ ;
Hajdu, J ;
Fulop, V .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (03) :440-455
[7]   S17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase [J].
Barelli, H ;
Petit, A ;
Hirsch, E ;
Wilk, S ;
De Nanteuil, G ;
Morain, P ;
Checler, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) :657-661
[8]   Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors [J].
Belyaev, A ;
Zhang, XM ;
Augustyns, K ;
Lambeir, AM ;
De Meester, I ;
Vedernikova, I ;
Scharpé, S ;
Haemers, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) :1041-1052
[9]  
BOHM SK, 1995, BIOCHEM J, V311, P835
[10]   KINETICS OF DIPEPTIDYL PEPTIDASE-IV PROTEOLYSIS OF GROWTH HORMONE-RELEASING FACTOR AND ANALOGS [J].
BONGERS, J ;
LAMBROS, T ;
AHMAD, M ;
HEIMER, EP .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (02) :147-153